Adami, P. E., Koutlianos, N., Baggish, A., Bermon, S., Cavarretta, E., Deligiannis, A., . . . Papadakis, M. (2022). Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: A position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology. European Journal of Preventive Cardiology, 29(3), 559–575. doi:10.1093/eurjpc/zwab198
Aikawa, K., Miyawaki, T., Hitaka, T., Imai, Y. N., Hara, T., Miyazaki, J., . . . Yamamoto, S. (2015). Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I. Bioorganic & Medicinal Chemistry, 23(10), 2568–2578. doi:10.1016/j.bmc.2015.03.032
Akhtar, N., Locke, D., & Stine, J. (2021). Harm by SARM: A case of drug-induced liver injury in an amateur bodybuilder. American Journal of Gastroenterology, 116(1), S1184–S1184. doi:10.14309/01.ajg.0000784936.08024.c4
Asano, M., Hitaka, T., Imada, T., Yamada, M., Morimoto, M., Shinohara, H., . . . Hasuoka, A. (2017). Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives. Bioorganic & Medicinal Chemistry Letters, 27(9), 1897–1901. doi:10.1016/j.bmcl.2017.03.038
Barbara, M., Dhingra, S., & Mindikoglu, A. L. (2020). Ligandrol (LGD-4033)-induced liver injury. ACG Case Reports Journal, 7(6). doi:10.14309/crj.0000000000000370
Bedi, H., Hammond, C., Sanders, D., Yang, H.-M., & Yoshida, E. M. (2021). Drug-induced liver injury from Enobosarm (Ostarine), a selective androgen receptor modulator. ACG Case Reports Journal, 8(1). doi:10.14309/crj.0000000000000518
Bertol, E., & Trignano, C. (2022). Poisoning caused by medicines and drugs of abuse. Toxics, 10(9). doi:10.3390/toxics10090515
Cardaci, T. D., Machek, S. B., Wilburn, D. T., Heileson, J. L., Harris, D. R., Cintineo, H. P., & Willoughby, D. S. (2022). LGD‐4033 and MK‐677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report. Experimental Physiology, 107(12), 1467–1476. doi:10.1113/ep090741
Catalani, V., Negri, A., Townshend, H., Simonato, P., Prilutskaya, M., Tippett, A., & Corazza, O. (2021). The market of sport supplement in the digital era: A netnographic analysis of perceived risks, side-effects and other safety issues. Emerging Trends in Drugs, Addictions, and Health, 1. doi:10.1016/j.etdah.2021.100014
Chakrabarty, R., Grainger, J., Goebel, C., Brooker, L., & George, A. (2021). “For research use only”: A comprehensive analysis of SARMs and related IPEDs purchased on local Australian websites between 2017 and 2018. Performance Enhancement & Health, 9(3-4). doi:10.1016/j.peh.2021.100201
Coletti, D., & Adamo, S. (2015). Will exercise mimetics hold promise? Journal of Pharmacovigilance, 3(2), article 1000e1138. doi:10.4172/2329-6887.1000e138
Dalton, J. T. (2017). The long and winding road for selective androgen receptor modulators. British Journal of Clinical Pharmacology, 83(10), 2131–2133. doi:10.1111/bcp.13345
Efimenko, I. V., Valancy, D., Dubin, J. M., & Ramasamy, R. (2021). Adverse effects and potential benefits among selective androgen receptor modulators users: A cross-sectional survey. International Journal of Impotence Research, 34(8), 757–761. doi:10.1038/s41443-021-00465-0
Fragkaki, A. G., Sakellariou, P., Kiousi, P., Kioukia‐Fougia, N., Tsivou, M., Petrou, M., & Angelis, Y. (2018). Human in vivo metabolism study of LGD‐4033. Drug Testing and Analysis, 10(11-12), 1635–1645. doi:10.1002/dta.2512
Goldman, A. L., Pope, H. G., & Bhasin, S. (2019). The health threat posed by the hidden epidemic of anabolic steroid use and body image disorders among young men. The Journal of Clinical Endocrinology & Metabolism, 104(4), 1069–1074. doi:10.1210/jc.2018-01706
Gould, H. P., Hawken, J. B., Duvall, G. T., & Hammond, J. W. (2021). Asynchronous bilateral achilles tendon rupture with selective androgen receptor modulators. JBJS Case Connector, 11(2), article 635. doi:10.2106/jbjs.Cc.20.00635
Health Canada. (2013). GW501516 - Serious Risks Associated With the Use of the Unauthorized Product - For the Public. Retrieved 17 January 2023 from https://recalls-rappels.canada.ca/en/alert-recall/gw501516-serious-risks-associated-use-unauthorized-product-public
Hilkens, L., Cruyff, M., Woertman, L., Benjamins, J., & Evers, C. (2021). Social media, body image and resistance training: Creating the perfect ‘me’ with dietary supplements, anabolic steroids and SARM’s. Sports Medicine - Open, 7(1), article 81. doi:10.1186/s40798-021-00371-1
Kanagalingam, G., Sostre Santiago, V., Kane, B., Shaw, J. C., Friedman, H., & Murthy, U. K. (2021). Selective androgen receptor modulator intake associated with liver injury in a patient with underlying heterozygous H63D and PIMZ mutation. American Journal of Therapeutics, 0(8 April 2021). doi:10.1097/mjt.0000000000001370
Khan, S., Fackler, J., Gilani, A., Murphy, S., & Polintan, L. (2022). Selective androgen receptor modulator induced hepatotoxicity. Cureus(15 February 2022), article 22239. doi:10.7759/cureus.22239
Kim, N. S., Choi, H. S., Lim, N. Y., Lee, J. H., Kim, H., & Baek, S. Y. (2022). Application of simultaneous analytical methods for selective androgen receptor modulator adulterated in dietary supplements advertised as muscle strengthening using UHPLC-PDA and LC–ESI–MS/MS. Chromatographia, 85(10-11), 895–919. doi:10.1007/s10337-022-04170-y
Kintz, P. (2021). The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete. Journal of Pharmaceutical and Biomedical Analysis, 207. doi:10.1016/j.jpba.2021.114433
Kintz, P., Gheddar, L., Paradis, C., Chinellato, M., Ameline, A., Raul, J.-S., & Oliva-Labadie, M. (2021). Peroxisome proliferator-activated receptor delta agonist (PPAR- δ) and selective androgen receptor modulator (SARM) abuse: Clinical, analytical and biological data in a case involving a poisonous combination of GW1516 (Cardarine) and MK2866 (Ostarine). Toxics, 9(10). doi:10.3390/toxics9100251
Koller, T., Vrbova, P., Meciarova, I., Molcan, P., Smitka, M., Adamcova Selcanova, S., & Skladany, L. (2021). Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review. World Journal of Clinical Cases, 9(16), 4062–4071. doi:10.12998/wjcc.v9.i16.4062
Lam, H., & Wong, S.-Y. (2021). At what cost: Drug-induced liver injury secondary to selective androgen receptor modulator. American Journal of Gastroenterology, 116(1), S1142–S1142. doi:10.14309/01.ajg.0000784452.64316.30
Leaney, A. E., Beck, P., Biddle, S., Brown, P., Grace, P. B., Hudson, S. C., & Mawson, D. H. (2020). Analysis of supplements available to UK consumers purporting to contain selective androgen receptor modulators. Drug Testing and Analysis, 13(1), 122–127. doi:10.1002/dta.2908
Leung, K., Yaramada, P., Goyal, P., Cai, C. X., Thung, I., & Hammami, M. B. (2022). RAD-140 drug-induced liver injury. Ochsner Journal, 22(4), 361–365. doi:10.31486/toj.22.0005
Li, S., & Laher, I. (2015). Exercise pills: At the starting line. Trends in Pharmacological Sciences, 36(12), 906–917. doi:10.1016/j.tips.2015.08.014
Machek, S. B., Cardaci, T. D., Wilburn, D. T., & Willoughby, D. S. (2020). Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review. Steroids, 164. doi:10.1016/j.steroids.2020.108753
Miklos, A. (2018). Selective androgen receptor modulators (SARMs) in the context of doping. Farmacia, 66(5), 758–762. doi:10.31925/farmacia.2018.5.3
Mohideen, H., Hussain, H., Dahiya, D. S., & Wehbe, H. (2023). Selective androgen receptor modulators: An emerging liver toxin. Journal of Clinical and Translational Hepatology, 11(1), 188–196. doi:10.14218/jcth.2022.00207
Narayanan, R., Coss, C. C., & Dalton, J. T. (2018). Development of selective androgen receptor modulators (SARMs). Molecular and Cellular Endocrinology, 465, 134–142. doi:10.1016/j.mce.2017.06.013
Padappayil, R. P., Chandini Arjun, A., Vivar Acosta, J., Ghali, W., & Mughal, M. S. (2022). Acute myocarditis from the use of selective androgen receptor modulator (SARM) RAD-140 (Testolone). Cureus(7 January 2022), article 21663. doi:10.7759/cureus.21663
Palibroda, N., Zlotar, O., Fedyaeva, S., & Avramenko, A. (2018). Dietary supplements for bodybuilding: Is it safe for the liver? INTERNATIONAL ACADEMY JOURNAL Web of Scholar, 5(6 (24)), 6–10. doi:10.31435/rsglobal_wos/12062018/5775
Solomon, Z. J., Mirabal, J. R., Mazur, D. J., Kohn, T. P., Lipshultz, L. I., & Pastuszak, A. W. (2019). Selective androgen receptor modulators: Current knowledge and clinical applications. Sexual Medicine Reviews, 7(1), 84–94. doi:10.1016/j.sxmr.2018.09.006
Thevis, M., & Schänzer, W. (2018). Detection of SARMs in doping control analysis. Molecular and Cellular Endocrinology, 464, 34–45. doi:10.1016/j.mce.2017.01.040
Van Wagoner, R. M., Eichner, A., Bhasin, S., Deuster, P. A., & Eichner, D. (2017). Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. Jama, 318(20), article 2004. doi:10.1001/jama.2017.17069
Vasilev, V., & Boyadjiev, N. (2020). Selective androgen receptor modulators (SARM) – a new temptation in sports. types, mode of action and side effects of their application: Review. Journal of Applied Sports Sciences, 2(2020), 107–115. doi:10.37393/jass.2020.02.9
Weinblatt, D., & Roy, S. (2022). Drug-induced liver injury secondary to enobosarm: A selective androgen receptor modulator. Journal of Medical Cases, 13(5), 244–248. doi:10.14740/jmc3937